Section 216-RICR-10-10-2.4 - Reporting RequirementsA. Health care facilities and/or health care providers as defined in § 2.2(A)(4) of this Part, shall be responsible to report to the Rhode Island Cancer Registry and the organization and/or agency approved by the Director, each reportable malignant disease indicated by test results, diagnosed and/or confirmed within the health care facility and/or by the health care provider on and after October 1, 1986, each reportable benign neoplasm of the brain or central nervous system indicated by test results, diagnosed and/or confirmed within the health care facility and/or by the health care provider on and after January 1, 1998, and each reportable in situ carcinomas of the cervix (also known as squamous intraepithelial neoplasia 3: CIN-3 or high-grade squamous epithelial lesion: HSIL) indicated by test results, diagnosed and/or confirmed within the health care facility and/or by the health care provider on and after January 1, 2018, including all histopathology and cytology specimens removed elsewhere but found to be positive for each reportable case upon initial reading or upon consultative reading at the health care facility and/or by the health care provider. Health care facilities and/or health care providers shall report each reportable case treated within the health care facility and/or by the health care provider if that case was diagnosed therein or thereby, or if the treatment therein or thereby is part of the first course of definitive treatment for the case.B. Each health care facility and/or health care provider shall electronically submit such data and information on reportable cases and shall meet data element requirements, format, completeness, quality, and timelines prescribed by: 1. Chapter VII "Record Layout Table"? of the "Standards Volume II"? of the "Central Cancer Registry Standards"? (Version 22, Revised October 28, 2021) published by the North American Association of Central Cancer Registries, incorporated herein by reference, not including any later editions or amendments thereof; and2. "Standards for Oncology Registry Entry"? (January 1, 2022) published by the Commission on Cancer, incorporated herein by reference, not including any later editions or amendments thereof.216 R.I. Code R. 216-RICR-10-10-2.4
Amended effective 1/18/2021
Amended effective 1/12/2022